Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: efficacy and toxicity. (Q55462206)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: efficacy and toxicity. |
scientific article |
Statements
1 reference
Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: efficacy and toxicity. (English)
1 reference
Petra Miglierini
1 reference
Mohamed Bouchekoua
1 reference
Benoit Rousseau
1 reference
Phong Dam Hieu
1 reference
Jean-Pierre Malhaire
1 reference
Olivier Pradier
1 reference
31 March 2012
1 reference
114
1 reference
9
1 reference
1222-1225
1 reference